NCT00560235 2015-10-28
Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
Pfizer
Phase 1/2 Completed
Clinical Trials
9 trialsNCT00474760 2013-12-17
Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors
Pfizer
Phase 1 Completed
NCT00927966 2013-11-14
RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms
Dana-Farber Cancer Institute
Phase 1 Completed
NCT00147537 2013-10-30
Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer
Pfizer
Phase 1/2 Completed
NCT01653158 2013-10-30
CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies
Pfizer
Phase 1 Completed
NCT00313781 2013-04-11
Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)
Pfizer
Phase 2 Completed
NCT00603538 2013-04-11
Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer
Pfizer
Phase 1 Completed
NCT00560573 2013-03-21
Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer
Pfizer
Phase 1 Completed
NCT01536145 2013-03-15
CP-751,871 Treatment For Patients With Multiple Myeloma
Pfizer
Phase 1 Completed